IRMD

$87.67+8.09%visit website

IRADIMED CORP

Market Cap

$1.1B

Live price × SEC shares (Oct 30, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

0.91

60mo monthly vs SPY

P/E (TTM)

46.9

TTM to Sep 2026 · diluted EPS

P/S (TTM)

12.5

TTM to Sep 2026 · revenue

P/B

10.5

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Revenue	22,692	21,979	20,466	24,203	89,340
Cost of revenue	5,660	5,165	5,306	5,747	21,878
Gross profit	17,032	16,814	15,160	18,456	67,462
Research & development	799	956	657	875	3,287
Total operating expenses	9,938	9,577	8,769	10,317	38,601
Operating income	7,094	7,237	6,391	8,139	28,861
Pretax income	7,791	7,769	6,888	8,668	31,116
Income tax	1,349	1,951	1,670	2,162	7,132
Net income	6,442	5,818	5,218	6,506	23,984
EPS (basic) ($)		0.46	0.41	0.51	1.88
EPS (diluted) ($)		0.45	0.41	0.51	1.87
Weighted avg. shares (basic)		12,783	12,784	12,787
Weighted avg. shares (diluted)		12,870	12,872	12,876

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Oct 30, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 50 more quarters, back to Jun 2013, with Tormere Pro.

Corporate Events (8-K)

7 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 30, 2026 accepted 8:37 AM ET	2.02Earnings release	Document SEC ↗
Aug 18, 2026 accepted 2:03 PM ET	8-K/A 2.02Earnings release	Document SEC ↗
Jul 31, 2026 accepted 8:15 AM ET	8.01Other events	Document SEC ↗
Jun 24, 2026 accepted 10:22 AM ET	5.07Shareholder vote	Document SEC ↗
May 1, 2026 accepted 8:45 AM ET	2.02Earnings release	Document SEC ↗
Feb 10, 2026 accepted 8:00 AM ET	2.02Earnings release	Document SEC ↗
Dec 8, 2025 accepted 8:30 AM ET	8.01Other events	Document SEC ↗
Nov 3, 2025 accepted 8:30 AM ET	2.02Earnings release	Document SEC ↗
Sep 2, 2025 accepted 8:00 AM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Aug 1, 2025 accepted 8:32 AM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

55%

W/W +27.1pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

0.06x

Avg Daily Selling (90d)

15.8 sh/day

Baseline Daily Selling

655 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-03	2026-09-08	ALLEN MONTY K	Director	Sale	1,419	$86.41	$123K	19.6K	View
2026-06-04	2026-06-04	Scharen-Guivel Hilda Frederique	Director	Sale	3,000	$95.00	$285K	5,598	View
2026-05-27	2026-05-28	Susi Roger E.	Director & CEO, President, Chairman	Sale	2,500	$91.95	$230K	2.17M	View
2026-05-26	2026-05-28	Susi Roger E.	Director & CEO, President, Chairman	Sale	5,000	$92.23	$461K	2.17M	View
2026-05-19	2026-05-20	Susi Roger E.	Director & CEO, President, Chairman	Sale	2,500	$87.88	$220K	2.17M	View

1–5 of 46

1 / 10

Recent News

IRADIMED (IRMD) Shares Moved, What Is Behind The Latest Attention?

Yahoo · 2026-11-03

IRADIMED (IRMD) Earnings And Guidance Raise The Question Of Whether The Stock Is A Bargain

Simply Wall St · 2026-11-02

IRadimed (IRMD) Stock Drops After Q3 Earnings Fail To Clear High Bar

Yahoo · 2026-11-01

IRadimed (IRMD) Stock Price Falls As Q3 Earnings Face Valuation Doubts

Simply Wall St · 2026-11-01

Is IRADIMED (IRMD) Fully Priced Based On Future Cash Flow?

Yahoo · 2026-10-31

IRadimed Corporation Q3 2026 Earnings Call Summary

Yahoo · 2026-10-30

Iradimed (IRMD) Q3 2026 Earnings Call Transcript

Yahoo · 2026-10-30

What iRadimed (IRMD) Said on Its Q3 Earnings Call

Yahoo · 2026-10-30

IRADIMED CORPORATION (IRMD) Q3 2026 Earnings Call Transcript

SeekingAlpha · 2026-10-30

Iradimed Q3 Revenue Rises 14% to $24.2 Million

Quiver Quantitative · 2026-10-30

IRadimed: Q3 Earnings Snapshot

Yahoo · 2026-10-30

IRADIMED CORPORATION Reports Third Quarter 2026 Financial Results

Yahoo · 2026-10-30

iRadimed Q3 2026 Earnings Call Transcript

Benzinga · 2026-10-30

iRadimed Q3 Adj. EPS $0.55, Inline, Sales $24.203M Beat $23.467M Estimate

Benzinga · 2026-10-30

iRadimed Narrows FY2026 GAAP EPS Guidance from $1.90-$2.05 to $1.90-$1.94 vs $1.94 Est

Benzinga · 2026-10-30

Informational purposes only, not investment advice.

IRMD

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

IRADIMED CORP (IRMD)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-09-03	ALLEN MONTY K	S	405	$34,971.75
2026-09-03	ALLEN MONTY K	S	1,014	$87,650.16
2026-06-04	Scharen-Guivel Hilda Frederique	S	1,234	$117,230
2026-06-04	Scharen-Guivel Hilda Frederique	S	1,766	$167,770
2026-05-27	Susi Roger E.	S	333	$30,839.13